Increasing the sample size when the unblinded interim result is promising
暂无分享,去创建一个
[1] J. Wittes. On changing a long‐term clinical trial midstream , 2002, Statistics in medicine.
[2] J. Denne,et al. Sample size recalculation using conditional power , 2001, Statistics in medicine.
[3] A L Gould,et al. Sample size re‐estimation: recent developments and practical considerations , 2001, Statistics in medicine.
[4] W. Shih. Sample size re‐estimation – journey for a decade , 2001, Statistics in medicine.
[5] Z. Shun,et al. Type I error in sample size re‐estimations based on observed treatment difference , 2001, Statistics in medicine.
[6] M. Proschan,et al. Internal pilot studies I: type I error rate of the naive t-test. , 1999, Statistics in medicine.
[7] D. DeMets,et al. The agonising negative trend in monitoring of clinical trials , 1999, The Lancet.
[8] L Fisher,et al. Statistical Inference for Self‐Designing Clinical Trials with a One‐Sided Hypothesis , 1999, Biometrics.
[9] S. Lorentsen,et al. Estimation of offspring production from a limited number of stage-structured censuses. , 1999, Biometrics.
[10] L D Fisher,et al. Self-designing clinical trials. , 1998, Statistics in medicine.
[11] J. Long,et al. Blinded sample size re-estimation with unequal variances and center effects in clinical trials , 1998 .
[12] W J Shih,et al. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. , 1997, Statistics in medicine.
[13] W J Shih,et al. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change. , 1995, Statistics in medicine.
[14] M. Proschan,et al. Designed extension of studies based on conditional power. , 1995, Biometrics.
[15] S. Day,et al. Internal pilot studies for estimating sample size. , 1994, Statistics in medicine.
[16] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[17] D L DeMets,et al. Monitoring of clinical trials: issues and recommendations. , 1993, Controlled clinical trials.
[18] Monitoring of clinical trials and interim analyses from a drug sponsor's point of view. , 1993, Statistics in medicine.
[19] A. Gould,et al. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .
[20] K Kim,et al. Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.
[21] A L Gould,et al. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. , 1992, Statistics in medicine.
[22] J. Wittes,et al. The role of internal pilot studies in increasing the efficiency of clinical trials. , 1990, Statistics in medicine.
[23] K K Lan,et al. The B-value: a tool for monitoring data. , 1988, Biometrics.
[24] D L Demets,et al. Practical aspects in data monitoring: a brief review. , 1987, Statistics in medicine.
[25] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[26] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[27] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .